default-output-block.skip-main
National | Health

Genes important in developing treatment

More awareness of the genetic make-up of Pacific island peoples would assist in their medical care by creating a more tailored approach to their treatment says a researcher at Victoria University of Wellington.

Molecular geneticist Dr Geoff Chambers, who is an alumnus researcher at Victoria's School of Biological Sciences, says the immune systems of Māori and Pasifika people are very different from those with European ancestry.

The findings are the latest to come out of a research project that has so far spanned 25 years.

Dr Chambers’ earlier investigations identified genetic markers that traced the origin of Austronesian people (Polynesian, Māori, Melanesian, Micronesian and people from parts of South East Asia) back to Taiwan. His work also used molecular methods for forensic identification and as indicators for a range of diseases, including alcoholism and diabetes.

New data from his on-going research shows that Māori and Pasifika people are genetically distinct from Europeans. “It goes some way to explaining why some autoimmune diseases that are relatively common in people of European descent—such as multiple sclerosis—are virtually unheard of among Māori and Pasifika,” says Dr Chambers. “It also partly explains why diseases such as type-2 diabetes are more common in Māori or Pasifika people.”

Dr Chambers says the research has implications for the public health system. “It’s really important for organisations like the bone marrow registry to know that the immune system markers are different, in order to increase the number of matched donors and help improve the outcome of transplants.

“The important underlying message is that the research demonstrates very clearly that genes which are important in medical genetics have a whole different repertoire in Māori and Pasifika people than they do in Europeans—we need to take account of that to ensure we have equity in medicine,” says Dr Chambers.